- EN
Stay informed
Media support
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:
Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 21 813 1711
Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 21 813 1711
EMCDDA and drug-related news
25.01.2012 Speech by Wolfgang Götz, EMCDDA Director at the Global forum on combating illicit drug trafficking and related threats, 25–27 January 2012, Brussels
‘We are facing a growing challenge to the way we protect our citizens from drug trafficking and the collateral damage that it brings with it’, said EMCDDA Director Wolfgang Götz in Brussels today on the eve of International Customs Day. Addressing participants at the opening of the World Customs Organization’s ‘Global forum on combating illicit drug trafficking and related threats’, he spoke of the ‘many opportunities’ but unfortunately also the ‘new threats’ brought by our modern joined-up world.
15.12.2011 Latest analysis highlights changing trends in illicit production of amphetamine in Europe
Increased capacity and sophistication in the illicit amphetamine market are among developments reviewed in the EMCDDA–Europol analysis Amphetamine: a European Union perspective in the global context. Published today, the report describes how patterns and trends are changing in the production and trafficking of this widely used synthetic stimulant and the chemicals used in its manufacture. It also looks at the people and organisations involved, and the scale of the problem in a global context.
15.12.2011 Registration opens for European summer school on illicit drugs
The Lisbon-based Instituto Superior das Ciências do Trabalho e da Empresa (ISCTE) and the EU drugs agency (EMCDDA) are currently collaborating on a summer school programme entitled: ‘Illicit drugs in Europe: supply, demand and public policies’. Registration opens today for the course which will take place in Lisbon from 2–13 July 2012.
14.12.2011 EMCDDA briefing paper highlights need for range of tools to counter threat of emerging drugs
The speed at which new psychoactive substances can appear and be distributed now challenges the established procedure of passing legislation to control a substance in each country,’ according to a new publication released today by the EU drugs agency (EMCDDA). ‘Responding to new psychoactive substances’ – the latest briefing in the series Drugs in focus – describes how policymakers are demanding ‘new, faster and effective ways of drug control’ that will protect public health and deter suppliers from circumventing controls.
09.12.2011 EMCDDA launches first European quality standards to improve drug prevention in the EU
‘Prevention’ is one of the first issues to be mentioned in the public debate on drugs, but evidence of what works in practice to prevent drug use is often overlooked. Today the EMCDDA launches the first European ‘how to’ guide on conducting high-quality drug prevention. Entitled European drug prevention quality standards: a manual for prevention professionals, it will be presented at an international conference hosted by the agency in Lisbon this week.
05.12.2011 International experts to examine the influence of social and economic environments on substance use
Leading international experts in prevention research will meet in Lisbon from 8–9 December to examine the influence of social and economic environments on substance use. Over 100 participants from some 20 countries will gather at the 2nd International Conference of the European Society for Prevention Research (EUSPR), hosted by the EU drugs agency (EMCDDA).
29.11.2011 ECDC and EMCDDA to host joint scientific seminar at the European Parliament on the eve of World AIDS Day
The European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will join forces in Brussels on the eve of World AIDS Day (30 November) to host a scientific seminar at the European Parliament. The seminar will bring prominent speakers to Brussels to discuss with MEPs ways to prevent and control infections among people who inject drugs and to address the risk and burden of HIV and AIDS-related infections, such as hepatitis B and C in EU countries.
28.11.2011 EMCDDA and ESPAD to scale up cooperation through new joint actions
The EMCDDA and the European School Survey Project on Alcohol and Other Drugs (ESPAD) pledged to scale up their cooperation today in a joint statement adopted at the 2011 ESPAD project meeting. The event, hosted by the EMCDDA in Lisbon (27–29 November), brings together participants from 39 European countries.
15.11.2011 EU drugs agency releases new analysis of Europe’s changing opioid problem
Heroin use continues to account for the largest share of drug-related diseases and deaths in the EU. The EU drugs agency (EMCDDA) estimates that there are over 1.3 million regular opioid users in the EU and Norway. And around half (51 %) of the drug users entering specialised treatment in Europe report opioids as their main problem drug.
Latest data published today show levels of regular opioid use to be relatively stable in Europe.
Page last updated: Wednesday, 25 January 2012